高濃度皮下生物製剤:課題と進歩
Guangli Hu1, Mikolaj Milewski1, Yogita Krishnamachari1
1Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, NJ 07065, United States.
Advanced drug delivery reviews
|February 8, 2026
まとめ
高用量皮下(SC)生物製剤は患者に利点をもたらしますが、課題にも直面しています。製剤、デバイス、分析における革新は、効果的なSC生物製剤の開発に不可欠です。
科学分野:
- 生物製剤開発
- 薬物送達システム
背景:
- 皮下(SC)投与は、利便性、アドヒアランス、コストのため、静脈内(IV)注入よりも生物製剤に適している。
- 大量の薬剤に対する高用量皮下製剤(HiSubQ)の需要が高まっている。
研究 の 目的:
- 製剤、生物製剤、デバイス、分析に焦点を当てたSC薬物開発の進歩をレビューする。
- 患者中心のSC生物製剤ソリューションを開発するための戦略を提案する。
主な方法:
- SC生物製剤の製剤、製造、デバイス開発、分析特性評価に関する現在の文献のレビュー。
- HiSubQ開発における課題と革新的なソリューションの特定。
主要な成果:
- SC投与はIV注入と比較して利点がある。
- HiSubQの開発は、タンパク質の不安定性や高粘度などの障害に直面している。
- タンパク質工学、製剤、デバイス、分析における革新が鍵となる。
結論:
- SC生物製剤の革新には学際的な協力が不可欠である。
- 戦術とロードマップは、市場の需要を満たす患者中心のSC生物製剤の開発を導くことができる。
関連する概念動画
Drug Products: Biologics, Biosimilars and Interchangeables
279
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
279
Drug Concentrations: Measurements
1.2K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
1.2K
Drug Concentration Versus Time Correlation
2.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
2.2K
Factors Affecting Drug Biotransformation: Biological
614
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
614
Drug Product Stability
277
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
277
Concentration Cells
25.9K
A concentration cell is a type of a voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
Consider the following voltaic cell:
25.9K


